Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Bone Turnover Biomarkers, CB2 and TRPV1 Polymorphisms as Potential Preventive Data in Osteoporosis and Perception of Improvement in Quality of Life in Women With Chronic Pain Treated With Medicinal Cannabis

NCT07783295 is registered in ClinicalTrials.gov with Associação Pan-Americana Multidisciplinar de Endocanabinologia as lead sponsor.

NCT NCT07783295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07783295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Bone Turnover Biomarkers, CB2 and TRPV1 Polymorphisms as Potential Preventive Data in Osteoporosis and Perception of Improvement in Quality of Life in Women With Chronic Pain Treated With Medicinal Cannabis
Lead sponsor
Associação Pan-Americana Multidisciplinar de Endocanabinologia
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 1, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, fibromyalgia, orofacial pain, osteoporosis